To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

NCT06216041 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

DRUG: IMM-H014
DRUG: Placebo
DRUG: IMM-H014 ( FE)
DRUG: Placebo ( FE)

Sponsor

Changchun Intellicrown Pharmaceutical Co. LTD